Evaluating the centralized purchasing policy for the treatment of hepatitis C: The Colombian CASE

The high cost of drugs for hepatitis C limits access and adherence to treatment. In 2017, the Colombian health care system decided to design a strategy. It consisted of centralized purchasing, regulations, clinical practice guidelines, and direct observation of the treatment and follow‐up of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez, Angela V., Trujillo, Antonio J., Mejia, Aurelio E., Contreras, Johnny D., Sharfstein, Joshua M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902741/
https://www.ncbi.nlm.nih.gov/pubmed/31857910
http://dx.doi.org/10.1002/prp2.552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902741/
https://www.ncbi.nlm.nih.gov/pubmed/31857910
http://dx.doi.org/10.1002/prp2.552

Ejemplares similares